Pablo A Gonzalez
Overview
Explore the profile of Pablo A Gonzalez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
132
Citations
2597
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Pacheco G, Andrade C, Galvez N, Vazquez Y, Rodriguez-Guilarte L, Abarca K, et al.
Front Immunol
. 2023 Aug;
14:1215893.
PMID: 37533867
Introduction: The human respiratory syncytial virus (hRSV) is responsible for most respiratory tract infections in infants. Even though currently there are no approved hRSV vaccines for newborns or infants, several...
22.
Tognarelli E, Duarte L, Farias M, Cancino F, Corrales N, Ibanez F, et al.
Antioxidants (Basel)
. 2023 Jun;
12(6).
PMID: 37371900
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections are highly prevalent in the human population and produce mild to life-threatening diseases. These viruses interfere with the function...
23.
Farias M, Diethelm-Varela B, Kalergis A, Gonzalez P
Crit Rev Microbiol
. 2023 Jun;
50(5):515-539.
PMID: 37348003
Lipids play essential roles in the cell as components of cellular membranes, signaling molecules, and energy storage sources. Lipid droplets are cellular organelles composed of neutral lipids, such as triglycerides...
24.
Henriquez A, Vargas J, Landahur C, Corrales N, Agurto-Munoz A, Gonzalez P, et al.
Biotechnol Rep (Amst)
. 2023 May;
38:e00798.
PMID: 37181274
Herpes simplex virus type 2 (HSV-2) is a human infectious agent with significant impact on public health due to its high prevalence in the population and its ability to elicit...
25.
Mendez C, Penaloza H, Schultz B, Pina-Iturbe A, Rios M, Moreno-Tapia D, et al.
EBioMedicine
. 2023 Apr;
91:104563.
PMID: 37099842
Background: The Omicron variant has challenged the control of the COVID-19 pandemic due to its immuno-evasive properties. The administration of a booster dose of a SARS-CoV-2 vaccine showed positive effects...
26.
Prado Y, Perez L, Eltit F, Echeverria C, Llancalahuen F, Tapia P, et al.
Thromb Res
. 2023 Jan;
223:7-23.
PMID: 36689805
Background: Oxidative stress derived from severe systemic inflammation promotes conversion from high-density lipoprotein HDL to oxidized HDL (oxHDL), which interacts with vascular endothelial cells (ECs). OxHDL acquires procoagulant features playing...
27.
Duarte L, Gatica S, Castillo A, Kalergis A, Bueno S, Riedel C, et al.
Microbes Infect
. 2022 Dec;
25(5):105084.
PMID: 36586461
Numerous studies relate the onset and severity of multiple sclerosis (MS) with viral infections. Herpes simplex virus type 1 (HSV-1), which is neurotropic and highly prevalent in the brain of...
28.
Soto J, Melo-Gonzalez F, Gutierrez-Vera C, Schultz B, Berrios-Rojas R, Rivera-Perez D, et al.
mBio
. 2022 Nov;
13(6):e0131122.
PMID: 36383021
Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The inactivated...
29.
Villalobos V, Garrido M, Reyes A, Fernandez C, Diaz C, Torres V, et al.
Front Immunol
. 2022 Nov;
13:1044334.
PMID: 36341447
Aging is a gradual and progressive deterioration of integrity across multiple organ systems that negatively affects gingival wound healing. The cellular responses associated with wound healing, such as collagen synthesis,...
30.
Galvez N, Pacheco G, Schultz B, Melo-Gonzalez F, Soto J, Duarte L, et al.
Elife
. 2022 Oct;
11.
PMID: 36226829
Background: The development of vaccines to control the coronavirus disease 2019 (COVID-19) pandemic progression is a worldwide priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine...